According to a new report from IntelMarketResearch, the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032, growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is driven by increasing recognition and diagnosis of rare phototoxic disorders, rising awareness of orphan diseases, and...